Microsoft Corporation’s (NASDAQ:MSFT) Surface Touch Cover might contain a defect, say a number of users, as complaints are coming from the Surface Forums that the Touch Cover splits at a seam near the spot where it magnetically connects to the Surface slate. One user in that forum said that the cover “in the middle, at the join to the screen, is peeling,” and that it seems the “top layer has come loose and is ruffling up.” The Guardian, which was first to report on the problem, says that Matthew Baxter-Reynolds, a Windows developer, has also complained.
Pfizer (NYSE:PFE): CVS Caremark Corporation’s (NYSE:CVS) pharmacy-benefit division intends to block coverage for 17 additional drugs starting on January 1st, adding to its list of more than 30 drugs blocked for the current year, according to the Wall Street Journal. The modifications affect the PBM’s standard formulary, which most employer clients use, and include Abbott Laboratories’ (NYSE:ABT) Androgel, Allergan’s (NYSE:AGN) Lumigan, Pfizer’s Genotropin and the diabetes drug Onglyza from Bristol-Myers Squibb Company (NYSE:BMY) and AstraZeneca (NYSE:AZN). CVS is adding three drugs back to the formulary for 2013, including Axiron plus Endo Health Solutions’ (NASDAQ:ENDP) Fortesta and Eli Lilly and Company’s (NYSE:LLY) Tradjenta.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
AT&T (NYSE:T) reports on its Public Policy blog that it will allow FaceTime video calls for iPhone 5 users alongside any AT&T Mobile Share plan, expanding it beyond customers who already have its new shared data plans.
Verizon Communications (NYSE:VZ) Chief Financial Officer Fran Shammo announced that his firm expects to have its launch of LTE technology ready nationwide in mid-2013, says Cnet.
Don’t Miss: Can Spectrum Help AT&T Catch Up to Verizon?